AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Assessing the pros and cons of zero based budgeting can guide your financial planning. Discover what works best for your situation.
28,655 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
A top Deutsche Bank economist warns that AI’s productivity gains may take years to materialize. If returns lag, risin...
Fidelity Investments’ leadership, led by Abby Johnson, has quietly built a decades-long crypto program that critics n...
NovaBridge Crypto cuts 12% of its workforce to accelerate its AI strategy, signaling a wider shift toward AI-driven e...
A couple with $4.2 million in retirement assets faces a $200,000 request from their 32-year-old daughter to fund a do...
Dell Technologies shares have surged about 120% in a blistering run, pushing the stock toward record levels as AI inf...
UBS uMINT yield-bearing collateral is now live on Bybit through a three‑party workflow, turning idle cash into produc...
Synergy One Lending will absorb Newrez's distributed retail mortgage operations under a strategic agreement, extendin...
Two KKR Co-CEOs bought a combined 175,000 shares in February, signaling confidence as the stock trades in the mid-$90...
With savings yields retreating as the Fed eases policy, two utility ETFs offer a compelling mix of income and upside....
A stock can drop today for many reasons—some temporary, some signaling a bigger issue. This guide shows you how to ev...
A famous wall street futurist contends Starlink’s subscription revenue alone could underpin SpaceX’s multi-trillion-d...